Hancock Jaffe Laboratories, Inc. (HJLI)
| Market Cap | 51.53M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.74M |
| Shares Out | 1.29M |
| EPS (ttm) | -7.54 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $5.87 |
| Previous Close | $6.06 |
| Change ($) | -0.19 |
| Change (%) | -3.14% |
| Day's Open | 6.06 |
| Day's Range | 5.86 - 6.13 |
| Day's Volume | 89,095 |
| 52-Week Range | 5.55 - 20.25 |
IRVINE, CA / ACCESSWIRE / April 7, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the United States ...
IRVINE, CA / ACCESSWIRE / April 5, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and ...
IRVINE, CA / ACCESSWIRE / March 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has submitted a...
Company to Move Forward with Application for VenoValve U.S. Pivotal Trial IRVINE, CA / ACCESSWIRE / January 12, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices tha...
IRVINE, CA / ACCESSWIRE / December 30, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that Dr. Hamed Ala...
Company Regains Compliance with NASDAQ Minimum Bid Requirement IRVINE, CA / ACCESSWIRE / December 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore ...
About HJLI
Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf... [Read more...]
| Industry Medical Devices | Founded 1987 |
| Stock Exchange NASDAQ | Ticker Symbol HJLI |
Analyst Forecasts
According to one analyst, the rating for HJLI stock is "Strong Buy" and the 12-month stock price forecast is 28.00.